Research progress of estimated plasma volume in heart failure
-
摘要:
充血可能由过度的神经激素激活引起, 表现为外周水肿和肺水肿，是影响心力衰竭(HF)患者预后的重要因素之一。因此，识别充血对诊断HF具有重要的临床意义。目前，临床评估充血的方法有限。估算的血浆容量(ePVS)被认为可用于评估充血，其具有无创性、可重复性。ePVS基于常规变量(体质量、血红蛋白及红细胞比容)的公式(Strauss公式、Duarte公式、Hakim公式)进行计算。本文就ePVS的研究进展进行综述，并讨论未来监测ePVS的临床研究方向。
Abstract:Hyperemia may be caused by excessive neurohormonal activation and is manifested as peripheral edema and pulmonary edema, which is one of the important factors affecting the prognosis of patients with heart failure (HF). Therefore, recognition of hyperemia is of great clinical significance in diagnosis HF. Currently, clinical methods for assessing hyperemia are limited. Estimated plasma volumes (ePVS) are considered to be noninvasive and reproducible for assessing hyperemia. EPVS was calculated based on the formula (Strauss, Duarte and Hakim formulas) of conventional variables (body mass, hemoglobin and erythrocyte volume). This article reviewed the progress of ePVS research and discussed the direction of clinical research in monitoring ePVS in the future.
-
Keywords:
- hyperemia /
- heart failure /
- plasma volume /
- capacity management /
- prognosis
-
-
[1] MASSARI F, SCICCHITANO P, IACOVIELLO M, et al. Multiparametric approach to congestion for predicting long-term survival in heart failure[J]. J Cardiol, 2020, 75(1): 47-52. doi: 10.1016/j.jjcc.2019.05.017
[2] 徐亚妹, 周京敏. 2019 ESC心力衰竭协会充血性心力衰竭利尿剂使用声明解读[J]. 中国循环杂志, 2019, 34(S1): 69-71. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH2019S1016.htm [3] MARTENS P, MULLENS W. How to tackle congestion in acute heart failure[J]. Korean J Intern Med, 2018, 33(3): 462-473. doi: 10.3904/kjim.2017.355
[4] PUGLIESE N R, MASI S, TADDEI S. The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure[J]. Heart Fail Rev, 2020, 25(1): 31-42. doi: 10.1007/s10741-019-09855-5
[5] HEUSCH G. Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what[J]. Am J Physiol Heart Circ Physiol, 2019, 316(6): H1439-H1446. doi: 10.1152/ajpheart.00139.2019
[6] STRAUSS M B, DAVIS R K, ROSENBAUM J D, et al. Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution[J]. J Clin Invest, 1951, 30(8): 862-868. doi: 10.1172/JCI102501
[7] DUARTE K, MONNEZ J M, ALBUISSON E, et al. Prognostic value of estimated plasma volume in heart failure[J]. JACC Heart Fail, 2015, 3(11): 886-893. doi: 10.1016/j.jchf.2015.06.014
[8] LONGO DL FAS, KASPER DL HSL, JAMESON JL LJ, et al. Harrison's Principles of Internal Medicine[M]. New York: McGraw–Hill, 2011: 529-531.
[9] LING H Z, FLINT J, DAMGAARD M, et al. Calculated plasma volume status and prognosis in chronic heart failure[J]. Eur J Heart Fail, 2015, 17(1): 35-43. doi: 10.1002/ejhf.193
[10] DEKKERS C C J, SJÖSTRÖM C D, GREASLEY P J, et al. Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2019, 21(12): 2667-2673. doi: 10.1111/dom.13855
[11] FUDIM M, MILLER W L. Calculated estimates of plasma volume in patients with chronic heart failure-comparison with measured volumes[J]. J Card Fail, 2018, 24(9): 553-560. doi: 10.1016/j.cardfail.2018.07.462
[12] 汝奎, 武冰琳, 姚鹏. 血浆容量预测慢性收缩性心力衰竭患者的预后价值[J]. 实用临床医药杂志, 2021, 25(18): 116-119, 132. doi: 10.7619/jcmp.20213126 [13] OZHAN H, BALABAN Y. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction[J]. Heart, 2010, 96(10): 791.
[14] GRODIN J L, PHILIPS S, MULLENS W, et al. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT[J]. Eur J Heart Fail, 2019, 21(5): 634-642. doi: 10.1002/ejhf.1407
[15] KOBAYASHI M, GIRERD N, DUARTE K, et al. Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction[J]. Clin Res Cardiol, 2020, 109(11): 1392-1401. doi: 10.1007/s00392-020-01639-4
[16] HUANG C Y, LIN T T, WU Y F, et al. Long-term prognostic value of estimated plasma volume in heart failure with preserved ejection fraction[J]. Sci Rep, 2019, 9(1): 14369. doi: 10.1038/s41598-019-50427-2
[17] POCOCK S J, MCMURRAY J J V, DOBSON J, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme[J]. Eur Heart J, 2008, 29(21): 2641-2650. doi: 10.1093/eurheartj/ehn420
[18] DUPONT M, SHRESTHA K, TANG W H W. Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure[J]. Eur J Heart Fail, 2011, 13(8): 820-822. doi: 10.1093/eurjhf/hfr092
[19] YOSHIHISA A, ABE S, SATO Y, et al. Plasma volume status predicts prognosis in patients with acute heart failure syndromes[J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(4): 330-338. doi: 10.1177/2048872617690889
[20] HUDSON S R, CHAN D, NG L L. Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study[J]. J R Soc Med, 2016, 109(9): 337-346. doi: 10.1177/0141076816661316
[21] KOBAYASHI M, DOUAIR A, COIRO S, et al. A combination of chest radiography and estimated plasma volume may predict in-hospital mortality in acute heart failure[J]. Front Cardiovasc Med, 2022, 8: 752915. doi: 10.3389/fcvm.2021.752915
[22] BARMPARAS G, LIOU D, LEE D, et al. Impact of positive fluid balance on critically ill surgical patients: a prospective observational study[J]. J Crit Care, 2014, 29(6): 936-941. doi: 10.1016/j.jcrc.2014.06.023
[23] MAZNYCZKA A M, BARAKAT M F, USSEN B, et al. Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery[J]. Heart, 2019, 105(13): 1020-1026. doi: 10.1136/heartjnl-2018-314246
[24] SHIMURA T, YAMAMOTO M, YAMAGUCHI R, et al. Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement[J]. ESC Heart Fail, 2021, 8(3): 1990-2001. doi: 10.1002/ehf2.13270
[25] KAWAI T, NAKATANI D, YAMADA T, et al. Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction[J]. Int J Cardiol Heart Vasc, 2021, 33: 100748.
[26] CHEN J, SHEN J Y, CAI D S, et al. Estimated plasma volume status (ePVS) is a predictor for acute myocardial infarction in-hospital mortality: analysis based on MIMIC-Ⅲ database[J]. BMC Cardiovasc Disord, 2021, 21(1): 530. doi: 10.1186/s12872-021-02338-2
[27] BINANAY C, CALIFF R M, HASSELBLAD V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial[J]. JAMA, 2005, 294(13): 1625-1633. doi: 10.1001/jama.294.13.1625
[28] 张小雪, 张玲, 周贤惠. 植入型监测装置在慢性心力衰竭患者中的应用进展[J]. 中华心律失常学杂志, 2020, 24(3): 333-336. doi: 10.3760/cma.j.cn.113859-20190419-00101 [29] CHARDOLI M, AHMADI M, SHAFE O, et al. Inferior vena cava diameter as a guide in hypotensive patients for appropriate saline therapy: an observational study[J]. Int J Crit Illn Inj Sci, 2018, 8(3): 160-164.
[30] MOOKADAM F, WARSAME T A, YANG H S, et al. Effect of positional changes on inferior vena cava size[J]. Eur J Echocardiogr, 2011, 12(4): 322-325. doi: 10.1093/ejechocard/jer018
[31] FINNERTY N M, PANCHAL A R, BOULGER C, et al. Inferior vena cava measurement with ultrasound: what is the best view and best mode[J]. West J Emerg Med, 2017, 18(3): 496-501. doi: 10.5811/westjem.2016.12.32489
[32] HOSHIKA Y, KUBOTA Y, MOZAWA K, et al. Effect of empagliflozin versus placebo on plasma volume status in patients with acute myocardial infarction and type 2 diabetes mellitus[J]. Diabetes Ther, 2021, 12(8): 2241-2248. doi: 10.1007/s13300-021-01103-0
[33] KOBAYASHI M, ROSSIGNOL P, FERREIRA J P, et al. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies[J]. Clin Res Cardiol, 2019, 108(5): 549-561. doi: 10.1007/s00392-018-1385-1
-
期刊类型引用(35)
1. 王雪雁. 综合护理干预在妊娠期糖尿病并发妊娠期高血压患者中的应用效果. 糖尿病新世界. 2022(11): 115-118+128 . 
百度学术
2. 张明珠，余毅宏. 不同时期的护理干预对妊娠期糖尿病孕妇分娩结局的影响. 糖尿病新世界. 2021(02): 117-119+123 . 百度学术
3. 王敏，张敬露，周长青. 综合护理干预对癫痫女性妊娠结局影响的系统评价. 检验医学与临床. 2021(08): 1127-1129 . 百度学术
4. 江惠. 针对性护理对妊娠糖尿病患者母婴并发症的预防效果. 糖尿病新世界. 2021(11): 107-110 . 百度学术
5. 巴丽丽，陈丽. 综合护理干预对前置胎盘患者临床治疗效果的影响. 当代护士(中旬刊). 2020(01): 62-63 . 百度学术
6. 姜清华. 综合护理干预用于产妇胎膜早破感染预防的效果分析. 基层医学论坛. 2020(03): 358-359 . 百度学术
7. 兰向朋. 医护一体化模式对妊娠糖尿病患者的影响. 河南医学高等专科学校学报. 2020(01): 100-102 . 百度学术
8. 林秀凤，叶少云. 糖尿病患儿实施综合护理干预的效果分析. 糖尿病新世界. 2020(01): 84-85 . 百度学术
9. 林芝花. 综合护理干预在妊娠糖尿病合并妊娠高血压中的应用. 糖尿病新世界. 2020(03): 150-151 . 百度学术
10. 朱明月. 妊娠期糖尿病孕产妇应用规范化护理干预的效果研究. 临床医药文献电子杂志. 2020(40): 107 . 百度学术
11. 苏兰叶，赵霞. 综合护理对地中海贫血孕妇妊娠结局及心理状态的影响. 国际护理学杂志. 2020(21): 3851-3854 . 百度学术
12. 郑美钗. 综合护理在妊高症患者围产期护理中的应用及对其胎儿窘迫发生率的影响分析. 心血管病防治知识(学术版). 2019(02): 73-75 . 百度学术
13. 许燕瑜. 个性化护理在急性心肌梗死患者院前急诊护理中的应用效果评价. 心血管病防治知识(学术版). 2019(03): 75-77 . 百度学术
14. 刘爱霞，王英辉. 妊娠高血压产妇中应用优质护理对妊娠结局的影响. 中国校医. 2019(09): 687-688+710 . 百度学术
15. 于雯. 产后综合护理对妊娠合并糖尿病产妇哺乳情况及身体康复的作用分析. 中国现代药物应用. 2019(21): 225-227 . 百度学术
16. 林巧云. 综合护理干预对妊娠期高血压孕妇睡眠和血压的影响. 世界睡眠医学杂志. 2019(12): 1708-1709 . 百度学术
17. 唐佳佳. 综合护理管理在妊娠糖尿病患者中的效果分析. 黑龙江中医药. 2019(05): 290-291 . 百度学术
18. 童玲. 浅谈妊娠糖尿病孕妇的护理干预措施及研究进展. 实用妇科内分泌电子杂志. 2019(32): 159+161 . 百度学术
19. 温丽娥，黄奕辉，戚艮有，陈尚轩，陈志红. 个体化护理干预在妊娠合并糖尿病孕妇围产期的应用. 中国医药科学. 2018(08): 188-190+223 . 百度学术
20. 江绍明. 产前护理干预对妊娠糖尿病患者妊娠结局的影响. 河南医学研究. 2018(10): 1898-1899 . 百度学术
21. 王丽娟，冯锦屏，彭莲梅，陈菲娜. 糖尿病合并妊娠致胎儿窘迫及其护理干预的临床效果. 齐齐哈尔医学院学报. 2018(08): 974-975 . 百度学术
22. 张玮. 老年性糖尿病并发肺炎的护理心得. 实用临床护理学电子杂志. 2018(19): 13+22 . 百度学术
23. 刘桂华，沈菊霞，韩丽. 试析临床护理路径在初诊妊娠期糖尿病(GDM)患者中的临床应用价值. 实用临床护理学电子杂志. 2018(21): 122+126 . 百度学术
24. 张玉秀. 综合护理干预对妊娠糖尿病患者妊娠结局的影响. 糖尿病新世界. 2018(07): 163-165 . 百度学术
25. 沈淑梅. 糖尿病合并妊娠致胎儿窘迫及其护理干预的临床效果. 中国卫生标准管理. 2018(05): 169-170 . 百度学术
26. 尹绪玲. 产后综合护理对妊娠合并糖尿病产妇的效果. 中国卫生标准管理. 2018(13): 186-187 . 百度学术
27. 辛国玲. 综合护理干预对妊娠糖尿病患者妊娠结局的影响. 医疗装备. 2018(02): 184-185 . 百度学术
28. 宋季玲. 层级护理对糖尿病孕产妇风险规避的作用分析. 中外女性健康研究. 2018(16): 138+159 . 百度学术
29. 张玉云. 围产期综合护理并心理护理对妊娠糖尿病患者的护理效果观察. 糖尿病新世界. 2018(15): 1-3+6 . 百度学术
30. 赵虹. 综合护理干预模式对糖尿病低血糖患者的临床效果观察. 糖尿病新世界. 2018(17): 129-131 . 百度学术
31. 贺娟，张君玉. 妇科疾病合并糖尿病患者的护理措施及效果研究. 中外医学研究. 2018(33): 98-99 . 百度学术
32. 高辉. 期待疗法在前置胎盘护理的效果及护理干预分析. 中外女性健康研究. 2018(21): 151-152 . 百度学术
33. 李小平，陈晶晶. 护理干预在预防孕产妇围术期感染中的应用价值分析. 中国继续医学教育. 2017(21): 230-232 . 百度学术
34. 许丽婷，张云娇. 妊娠合并糖尿病患者围产期护理干预. 糖尿病新世界. 2017(15): 141-142 . 百度学术
35. 王亚男. 个性化护理干预在妊娠期糖尿病致早产预防中的应用效果分析. 系统医学. 2017(13): 154-156 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 253
- HTML全文浏览量: 123
- PDF下载量: 23
- 被引次数: 35
下载:
苏公网安备 32100302010246号
